Back

SNO Annual Meeting

E-Talks: Group 1: Health Outcomes/Neurological Complications of Cancer and Cancer Therapy/Quality of Life/Radiotherapy/Surgical Therapy/CNS Metastases

11/22/2019

7:30 PM - 8:30 PM

Location: Wildflower A

Author(s)

ab

asaf berger

Tel-Aviv Medical Center

E-Talk Presenter(s)

Sophia Chernikova, MS, PhD

Senior Research Scientist
Department of Neurosurgery, Stanford University

Author(s)

SI

Suzanne IJpelaar

University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery

E-Talk Presenter(s)

Kyung Hwan Kim

Clinical assistant professor
Dept. of Neurosurgery, Chungnam National University Hospital
AK

Amanda King, PhD, APNP-BC

Postdoctoral Fellow
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
JL

Jin-Shei Lai

Northwestern University
Ashlee Loughan

Virginia Commonwealth University, Massey Cancer Center

Author(s)

KM

Kathrin Milbury

Associate Professor
MD Anderson Cancer Center

E-Talk Presenter(s)

Katherine Selwa

Medical Student
University of Michigan
Martin Tom, MD

Resident, PGY5
Cleveland Clinic
KT

Kristen Triebel

Associate Professor in Neurology
University of Alabama at Birmingham
Kathleen Van Dyk, PhD

Assistant Professor
UCLA - Semel Institute, Dept. of Psychiatry
Tobias Walbert

Co-Director Hermelin Brain Tumor Center at Henry Ford Health System Detroit
Henry Ford Health System
Victoria Wykes

Senior Clinical Lecturer/Honorary Consultant Neurosurgery
University of Birmingham

Author(s)

SY

Shlomit Yust-Katz

rabin medical center
Sarah Braun

Virginia Commonwealth University
VD

Vijaya Donthireddy

Henry Ford
SG

Stewart Goldman

Pediatrics, Northwestern University
BH

Brandon F. Heimberg

Division of Geriatric Psychiatry, UCLA
Seon-Hwan Kim

Professor
Dept. of Neurosurgery, Chungnam National University Hospital
AL

Anna Laucis

University of Michigan
KM

Kyler Maulhauser

University of Alabama at Birmingham
SM

Simon McElligott

University College London Hospital
DP

Dina Polyak

Post-doctoral researcher
Stanford University
DR

David Routman

Mayo Clinic
LS

Lonni Schultz

Henry Ford Hospital
Dorela Shuboni-Mulligan

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
GT

Garry Tzarfati

Tel-Aviv Medical Center
EV

Emma Van Kessel

University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery

E-Talk Presenter(s)

Shiao- Pei Weathers

Assistant Professor
University of Texas MD Anderson Cancer Center

Author(s)

JC

Justin Choi

Department of Neurology, UCLA
MC

Mathias Costa

Tel-Aviv Medical Center
JD

Jiaojiao Deng

Stanford University
SD

Sania Durrani

Coord of Clinical Studies
MD Anderson Cancer Center
JF

John Fiveash

Professor of Radiation Oncology
University of Alabama at Birmingham
MH

Mariya Husain

Virginia Commonwealth University
EH

Eugene Hwang

Children’s National Medical Center
NL

Nadia Laack

Mayo Clinic/Accruals for Rochester Methodist Hospital (NCCTG)
TL

Theodore Lawrence

University of Michigan
JL

Jung-Il Lee

Samsung Medical Center, Sungkyunkwan University School of Medicine
jacob mandel

Baylor College of Medicine
JR

Joy Roach

University Hospital Southampton
James Snyder, DO

Physician
Henry Ford Health System
MV

Martine Van Zandvoort

University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery
EV

Elizabeth Vera

Mathematical Statistician
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
HA

Hussna Abunafeesa

Henry Ford
FA

Farah Aslanzadeh

Virginia Commonwealth University
Sonja Crandon

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
FD

Filip De Vos

University Medical Center Utrecht, Cancer Center, Department of Medical Oncology
JD

Jonathan Duffill

University Hospital Southampton
KF

Kelsey Frechette

Mayo Clinic
LJ

Larry Junck

Department of Neurology, University of Michigan medical School
MK

Mehmet Kocak

University of Tennessee Health Science Center
DK

Doo-Sik Kong

Samsung Medical Center
YL

Yisheng Li

Associate Professor
MD Anderson Cancer Center
DM

Dario Marrotta

Medical Student
Alabama College of Osteopathic Medicine
CR

Catalina Raymond

UCLA
MS

Marga Serafimova

Tel-Aviv Medical Center
AS

Aarushi Suneja

Henry Ford Health System
ST

Sheila Tsau

Stanford University
Orwa Aboud

Clinical Fellow
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
RB

Rachel Boutte

Virginia Commonwealth University
CC

Cindy Carmack

Professor
MD Anderson Cancer Center
KC

Kerriann Casey

Stanford University
KC

Kyle Cuneo

University of Michigan
MG

Meredith Gammon

University of Alabama at Birmingham
AK

Akiva Korn

Tel-Aviv Medical Center
RL

Rishi Lulla

Brown University
DP

Deborah Park

Cleveland Clinic
NP

Neha Patil

Henry Ford
HS

Ho Jun Seol

Samsung Medical Center
Joost Verhoeff

University Medical Center Utrecht, Cancer Center, Department of Radiotherapy
Chencai Wang, PhD

Postdoctoral Fellow
UCLA
CW

Crispin Weidmann

University Hospital Southampton
TA

Tali Alfassi

Tel-Aviv Medical Center
RA

Ramya Antony

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
EB

Eduardo Bruera

Chair
MD Anderson Cancer Center
GD

Girish Dhall

University of Alabama-Birmingham
PG

Paul Grundy

University Hospital Southampton
EJ

Eli Johnson

Stanford University
Michelle Kim, MD

Associate Professor
University of Michigan
AL

Albert Lai

Professor in Residence
Department of Neurology, UCLA
AL

Autumn Lanoye

Virginia Commonwealth University
DN

Do-Hyun Nam

Samsung Medical Center
PR

Pierre Robe

University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery
DV

David Vance

University of Alabama at Birmingham
WW

Wei (Auston) Wei

Taussig Cancer Institute
DY

Dhiraj Yadav

Henry Ford
DA

Daniel Aviram

Tel-Aviv Medical Center
HB

Hriday Bhambhvani

Stanford University
LB

Lisa Boris

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Timothy Cloughesy

Professor
University of California Los Angeles
HJ

Hiba Jabbour-Aida

Henry Ford
ML

Marc Leyrer

Wake Forest
LN

Louis Nabors, MD

Professor of Neurology
University of Alabama at Birmingham
NR

Nathan Robison

Children’s Hospital Los Angeles

E-Talk Presenter(s)

Tom Snijders, MD PhD

neurologist/neuro-oncologist
University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery

Author(s)

DW

Daniel Wahl

University of Michigan
CB

Christine Bryla

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Benjamin Ellingson, PhD, MS

Professor
University of California Los Angeles
AK

Alon Kashinian

Tel-Aviv Medical Center
LK

Lina Khoeur

Stanford University
AO

Arzu Onar-Thomas

St. Jude Children’s Research Hospital
DP

David Peereboom

Professor
Cleveland Clinic
Yoshie Umemura, MD

Assistant Professor
University of Michigan
JW

Jimin Wu

University of Texas MD Anderson Cancer Center
Manmeet Ahluwalia

Director Brain Metastases Research Program
Cleveland Clinic
EB

Eric Burton

NCI
ID

Ira Dunkel

Memorial Sloan Kettering Cancer Center
PN

P. Leia Nghiemphu

Department of Neurology, UCLA
ZR

Zvi Ram

Tel-Aviv Medical Center
GS

Geoff Stanley

Stanford University
Ying Yuan

MD anderson
Samuel Chao

Associate Professor / Full Staff
Cleveland Clinic
CC

Christine Cordova, MD

Assistant Professor
NYU Langone

E-Talk Presenter(s)

rachel grossman

Vice Chairman, Department of Neurosurgery Tel-Aviv Medical Center
Tel-Aviv Medical Center

Author(s)

KT

Kevin Tran

Stanford University
ST

Spiridon Tsavachidis

Baylor College of Medicine
IC

Ian Connolly

Stanford University
CG

Carrie Gartland

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
John Suh

Chairman, Dept. of Radiation Oncology
Cleveland Clinic Foundation

E-Talk Presenter(s)

Tobias Walbert

Co-Director Hermelin Brain Tumor Center at Henry Ford Health System Detroit
Henry Ford Health System

Author(s)

MB

Melissa Bondy

Baylor College of Medicine
EG

Ewa Grajkowska

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
AJ

Annie Joyce

Stanford University
EM

Erin Murphy

Cleveland Clinic
Terri Armstrong

Senior Investigator and Deputy Branch Chief
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
YL

Yingmei Li

Stanford University
Marta Penas-Prado, MD

Associate Research Physician
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
JR

Jennifer Reyes

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Rv

Rie von Eyben

Stanford University
Nicole Leggiero, BS

CRTA Post-Baccalaureate fellow
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Seema Nagpal, MD

Clinical Associate Professor
Stanford School of Medicine
Melanie Hayden Gephart

Associate Professor of Neurosurgery
Stanford University
CS

Christine Siegel

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
BT

Brett Theeler

National Institutes of Health
KW

Kathleen Wall

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Jing Wu, MD, PhD

Investigator
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
MG

Mark Gilbert

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Terri Armstrong

Senior Investigator and Deputy Branch Chief
Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Presentations:

7:30 PM - 7:34 PM
Multi-institutional analysis of high-risk WHO grade II oligodendroglioma treated with adjuvant radiotherapy plus temozolomide (TMZ) versus procarbazine, lomustine, and vincristine (PCV)
Martin Tom, MD – Cleveland Clinic; David Routman – Mayo Clinic; Nadia N. Laack – Mayo Clinic/Accruals for Rochester Methodist Hospital (NCCTG); Kelsey Frechette – Mayo Clinic; Deborah Park – Cleveland Clinic; Wei (Auston) Wei – Taussig Cancer Institute; Marc Leyrer – Wake Forest; David Peereboom – Cleveland Clinic; Manmeet S. Ahluwalia – Cleveland Clinic; Samuel Chao – Cleveland Clinic; John H. Suh – Cleveland Clinic Foundation; Erin Murphy – Cleveland Clinic
7:34 PM - 7:38 PM
Efficacy of fractionated gamma knife radiosurgery for orbital cavernous hemangioma: 10-year experience at a single institution
Kyung Hwan Kim – Dept. of Neurosurgery, Chungnam National University Hospital; Seon-Hwan Kim – Dept. of Neurosurgery, Chungnam National University Hospital; Jung-Il Lee – Samsung Medical Center, Sungkyunkwan University School of Medicine; Doo-Sik Kong – Samsung Medical Center; Ho Jun Seol – Samsung Medical Center; Do-Hyun Nam – Samsung Medical Center
7:38 PM - 7:42 PM
Improved survival in CNS lymphoma with salvage low-dose whole-brain radiotherapy with focal boost and concurrent temozolomide
Katherine E. Selwa – University of Michigan; Anna M. Laucis – University of Michigan; Theodore Lawrence – University of Michigan; Larry Junck – Department of Neurology, University of Michigan medical School; Kyle Cuneo – University of Michigan; Michelle Kim – University of Michigan; Daniel Wahl – University of Michigan; Yoshie Umemura – University of Michigan
7:42 PM - 7:46 PM
Evaluation of dynamin 2 (DNM2) as a therapeutic target in leptomeningeal metastatic disease
Sophia B. Chernikova, MS, PhD – Department of Neurosurgery, Stanford University; Dina Polyak – Stanford University; Jiaojiao Deng – Stanford University; Sheila Tsau – Stanford University; Kerriann Casey – Stanford University; Eli Johnson – Stanford University; Hriday Bhambhvani – Stanford University; Lina Khoeur – Stanford University; Geoff Stanley – Stanford University; Kevin Tran – Stanford University; Ian Connolly – Stanford University; Annie Joyce – Stanford University; Yingmei Li – Stanford University; Rie von Eyben – Stanford University; Seema Nagpal, MD – Stanford School of Medicine; Melanie Hayden Gephart – Stanford University
7:46 PM - 7:50 PM
Outcomes and correlations between legacy quality of life measures (EORTC-C30/EORTC-BN20) and the electronic quality of life measuring system NIH-PROMIS in glioblastoma patients
Tobias Walbert – Henry Ford Health System; Lonni Schultz – Henry Ford Hospital; James Snyder, DO – Henry Ford Health System; Aarushi Suneja – Henry Ford Health System
7:50 PM - 7:54 PM
Patients’/parents’ experiences of receiving Optune delivered tumor treatment fields: A Pediatric Brain Tumor Consortium Study: PBTC-048
Jin-Shei Lai – Northwestern University; Stewart Goldman – Pediatrics, Northwestern University; Eugene Hwang – Children’s National Medical Center; Mehmet Kocak – University of Tennessee Health Science Center; Rishi Lulla – Brown University; Girish Dhall – University of Alabama-Birmingham; Nathan Robison – Children’s Hospital Los Angeles; Arzu Onar-Thomas – St. Jude Children’s Research Hospital; Ira Dunkel – Memorial Sloan Kettering Cancer Center
7:54 PM - 7:58 PM
Acceptability Randomized Controlled Trial a Couples-Based Mind-Body Intervention for Patients with High Grade Glioma and their Partners
Kathrin Milbury – MD Anderson Cancer Center; Shiao- Pei Weathers – University of Texas MD Anderson Cancer Center; Sania Durrani – MD Anderson Cancer Center; Yisheng Li – MD Anderson Cancer Center; Cindy Carmack – MD Anderson Cancer Center; Eduardo Bruera – MD Anderson Cancer Center
7:58 PM - 8:02 PM
Clinical predictive model for the development of venous thromboembolism in glioblastoma
Shlomit Yust-Katz – rabin medical center; Vijaya Donthireddy – Henry Ford; jacob mandel – Baylor College of Medicine; Hussna Abunafeesa – Henry Ford; Neha Patil – Henry Ford; Dhiraj Yadav – Henry Ford; Hiba Jabbour-Aida – Henry Ford; Jimin Wu – University of Texas MD Anderson Cancer Center; Ying Yuan – MD anderson; Spiridon Tsavachidis – Baylor College of Medicine; Tobias Walbert – Henry Ford Health System; Melissa L. Bondy – Baylor College of Medicine; Terri S. Armstrong – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
8:02 PM - 8:06 PM
Existential Distress: Unaddressed Concerns for Adult Neuro-oncology Patients
Ashlee R. Loughan – Virginia Commonwealth University, Massey Cancer Center; Sarah E. Braun – Virginia Commonwealth University; Mariya Husain – Virginia Commonwealth University; Farah Aslanzadeh – Virginia Commonwealth University; Rachel Boutte – Virginia Commonwealth University; Autumn Lanoye – Virginia Commonwealth University
8:06 PM - 8:10 PM
The importance of sleep disturbance in primary brain tumor (PBT) patients: Clinical characteristics & co-occurrence with tumor-related & psychological symptoms
Amanda King, PhD, APNP-BC – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Dorela Shuboni-Mulligan – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Elizabeth Vera – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Sonja Crandon – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Orwa Aboud – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Ramya Antony – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Lisa Boris – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Christine Bryla – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Eric Burton – NCI; Christine Cordova, MD – NYU Langone; Carrie Gartland – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Ewa Grajkowska – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Marta Penas-Prado – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Jennifer Reyes – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Nicole Leggiero – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Christine Siegel – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Brett Theeler – National Institutes of Health; Kathleen Wall – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Jing Wu – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Mark R. Gilbert – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Terri S. Armstrong – Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
8:10 PM - 8:14 PM
Day-case image-guided biopsy for brain tumours: A decade of experience from a single neurosurgical unit in the United Kingdom
Victoria Wykes – University of Birmingham; Simon McElligott – University College London Hospital; Joy Roach – University Hospital Southampton; Jonathan Duffill – University Hospital Southampton; Crispin Weidmann – University Hospital Southampton; Paul Grundy – University Hospital Southampton
8:14 PM - 8:18 PM
The incidence and impact of post-operative stroke in surgery for LGG
asaf berger – Tel-Aviv Medical Center; Garry Tzarfati – Tel-Aviv Medical Center; Mathias Costa – Tel-Aviv Medical Center; Marga Serafimova – Tel-Aviv Medical Center; Akiva Korn – Tel-Aviv Medical Center; Tali Alfassi – Tel-Aviv Medical Center; Daniel Aviram – Tel-Aviv Medical Center; Alon Kashinian – Tel-Aviv Medical Center; Zvi Ram – Tel-Aviv Medical Center; rachel grossman – Tel-Aviv Medical Center
8:18 PM - 8:22 PM
Relationship between cognitive function, mood, and functioning in glioma survivors
Kathleen Van Dyk, PhD – UCLA - Semel Institute, Dept. of Psychiatry; Brandon F. Heimberg – Division of Geriatric Psychiatry, UCLA; Justin Y. Choi – Department of Neurology, UCLA; Catalina Raymond – UCLA; Chencai Wang, PhD – UCLA; Albert Lai – Department of Neurology, UCLA; Timothy F. Cloughesy – University of California Los Angeles; Benjamin M. Ellingson – University of California Los Angeles; P. Leia Nghiemphu – Department of Neurology, UCLA
8:22 PM - 8:26 PM
Treatment decision making in the setting of advanced cancer
Kristen Triebel – University of Alabama at Birmingham; Kyler Maulhauser – University of Alabama at Birmingham; John Fiveash – University of Alabama at Birmingham; Dario Marrotta – Alabama College of Osteopathic Medicine; Meredith Gammon – University of Alabama at Birmingham; David Vance – University of Alabama at Birmingham; Louis B. Nabors – University of Alabama at Birmingham
8:26 PM - 8:30 PM
Cognitive deficits as a predictor of the course of treatment in diffuse glioma
Suzanne M. IJpelaar – University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery; Emma Van Kessel – University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery; Martine J. Van Zandvoort – University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery; Filip Y. De Vos – University Medical Center Utrecht, Cancer Center, Department of Medical Oncology; Joost J. Verhoeff – University Medical Center Utrecht, Cancer Center, Department of Radiotherapy; Pierre A. Robe – University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery; Tom J. Snijders – University Medical Center Utrecht, Brain Center, Department of Neurology & Neurosurgery